Back to Search
JORGE BRIONES, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1346369618Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RPH 54263(CA)
Research & Publications (20)
Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.
PMID 19309400·Histopathology·2009
8-other
Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.
PMID 12671023·J Natl Cancer Inst·2003
7-preclinical
In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma.
PMID 12036933·Cancer Res·2002
7-preclinical
Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.
PMID 19224854·J Clin Oncol·2009
4-observational
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
PMID 19135939·Biol Blood Marrow Transplant·2009
8-other
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen.
PMID 19148841·Cytotherapy·2009
4-observational
Emerging therapies for patients with advanced chronic lymphocytic leukaemia.
PMID 19643519·Blood Rev·2009
6-review
Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysis.
PMID 19596701·Ann Oncol·2009
8-other
Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.
PMID 19398963·Bone Marrow Transplant·2009
8-other
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
PMID 19388937·Br J Haematol·2009
8-other
Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.
PMID 18983609·Histopathology·2008
8-other
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
PMID 18445689·Blood·2008
8-other
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
PMID 18303032·Ann Oncol·2008
3-trial
High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.
PMID 18223288·Haematologica·2008
3-trial
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
PMID 18172266·Clin Cancer Res·2008
3-trial
NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
PMID 17959301·Exp Hematol·2008
8-other
Early clinical impact of iron overload in stem cell transplantation. A prospective study.
PMID 17279415·Ann Hematol·2007
3-trial
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.
PMID 18024397·Haematologica·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2425 GEARY BLVD
SAN FRANCISCO, CA 94115 - Phone
- (415) 833-2000
Quick Facts
- NPI
- 1346369618
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile